nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SHMT1—breast cancer	0.584	1	CbGaD
Glycine—Aminocaproic Acid—PLG—breast cancer	0.00307	1	CrCbGaD
Glycine—BAAT—endocrine gland—breast cancer	0.00232	0.0202	CbGeAlD
Glycine—GLDC—nipple—breast cancer	0.00181	0.0158	CbGeAlD
Glycine—GLYAT—adipose tissue—breast cancer	0.0018	0.0158	CbGeAlD
Glycine—ALAS1—mammary gland—breast cancer	0.00173	0.0151	CbGeAlD
Glycine—PIPOX—nipple—breast cancer	0.00169	0.0147	CbGeAlD
Glycine—GCAT—nipple—breast cancer	0.00163	0.0143	CbGeAlD
Glycine—GARS—mammary gland—breast cancer	0.00158	0.0138	CbGeAlD
Glycine—SLC32A1—pituitary gland—breast cancer	0.00151	0.0132	CbGeAlD
Glycine—GLYATL1—endocrine gland—breast cancer	0.00149	0.013	CbGeAlD
Glycine—ALAS1—nipple—breast cancer	0.00143	0.0125	CbGeAlD
Glycine—GLYATL2—bone marrow—breast cancer	0.00142	0.0124	CbGeAlD
Glycine—GPR18—endometrium—breast cancer	0.0014	0.0123	CbGeAlD
Glycine—GLYAT—endocrine gland—breast cancer	0.0014	0.0123	CbGeAlD
Glycine—SHMT2—mammary gland—breast cancer	0.00137	0.012	CbGeAlD
Glycine—ALAS2—adipose tissue—breast cancer	0.00137	0.0119	CbGeAlD
Glycine—ALAS1—Estradiol—Fulvestrant—breast cancer	0.00131	0.353	CbGdCrCtD
Glycine—GARS—nipple—breast cancer	0.0013	0.0114	CbGeAlD
Glycine—SLC6A9—adrenal gland—breast cancer	0.0013	0.0114	CbGeAlD
Glycine—GLRB—mammary gland—breast cancer	0.00129	0.0112	CbGeAlD
Glycine—GPR18—adipose tissue—breast cancer	0.00126	0.011	CbGeAlD
Glycine—ALAS2—female reproductive system—breast cancer	0.00126	0.011	CbGeAlD
Glycine—SHMT1—mammary gland—breast cancer	0.00125	0.0109	CbGeAlD
Glycine—ALAS2—bone marrow—breast cancer	0.00119	0.0104	CbGeAlD
Glycine—GCSH—adipose tissue—breast cancer	0.00119	0.0104	CbGeAlD
Glycine—GPR18—female reproductive system—breast cancer	0.00116	0.0102	CbGeAlD
Glycine—SHMT2—nipple—breast cancer	0.00114	0.00992	CbGeAlD
Glycine—GPR18—adrenal gland—breast cancer	0.00113	0.00991	CbGeAlD
Glycine—GPR18—bone marrow—breast cancer	0.0011	0.00959	CbGeAlD
Glycine—GLDC—endometrium—breast cancer	0.00109	0.00952	CbGeAlD
Glycine—GCSH—female reproductive system—breast cancer	0.00109	0.00952	CbGeAlD
Glycine—GARS—embryo—breast cancer	0.00108	0.00941	CbGeAlD
Glycine—ALAS2—endocrine gland—breast cancer	0.00106	0.00929	CbGeAlD
Glycine—GCSH—adrenal gland—breast cancer	0.00106	0.00929	CbGeAlD
Glycine—GCAT—skin of body—breast cancer	0.00105	0.00914	CbGeAlD
Glycine—GNMT—pituitary gland—breast cancer	0.00104	0.00909	CbGeAlD
Glycine—SHMT1—nipple—breast cancer	0.00103	0.00903	CbGeAlD
Glycine—PIPOX—endometrium—breast cancer	0.00102	0.00889	CbGeAlD
Glycine—GCSH—female gonad—breast cancer	0.000991	0.00866	CbGeAlD
Glycine—GCAT—endometrium—breast cancer	0.000987	0.00862	CbGeAlD
Glycine—GLDC—pituitary gland—breast cancer	0.000986	0.00861	CbGeAlD
Glycine—GPR18—endocrine gland—breast cancer	0.000984	0.0086	CbGeAlD
Glycine—AGXT2—female reproductive system—breast cancer	0.000966	0.00844	CbGeAlD
Glycine—AGXT—endocrine gland—breast cancer	0.000962	0.0084	CbGeAlD
Glycine—GNMT—female reproductive system—breast cancer	0.000952	0.00832	CbGeAlD
Glycine—GNMT—adrenal gland—breast cancer	0.000929	0.00812	CbGeAlD
Glycine—GCSH—endocrine gland—breast cancer	0.000922	0.00805	CbGeAlD
Glycine—PIPOX—pituitary gland—breast cancer	0.000921	0.00804	CbGeAlD
Glycine—PIPOX—adipose tissue—breast cancer	0.000917	0.00801	CbGeAlD
Glycine—GLDC—female reproductive system—breast cancer	0.000903	0.00789	CbGeAlD
Glycine—GCAT—pituitary gland—breast cancer	0.000893	0.0078	CbGeAlD
Glycine—GCAT—adipose tissue—breast cancer	0.00089	0.00777	CbGeAlD
Glycine—GLDC—adrenal gland—breast cancer	0.000881	0.0077	CbGeAlD
Glycine—ALAS1—endometrium—breast cancer	0.000865	0.00756	CbGeAlD
Glycine—GARS—skin of body—breast cancer	0.000836	0.0073	CbGeAlD
Glycine—PIPOX—adrenal gland—breast cancer	0.000823	0.00718	CbGeAlD
Glycine—AGXT2—endocrine gland—breast cancer	0.000818	0.00714	CbGeAlD
Glycine—GNMT—endocrine gland—breast cancer	0.000806	0.00704	CbGeAlD
Glycine—GCAT—adrenal gland—breast cancer	0.000798	0.00697	CbGeAlD
Glycine—ALAS1—uterus—breast cancer	0.000797	0.00696	CbGeAlD
Glycine—GARS—endometrium—breast cancer	0.000788	0.00688	CbGeAlD
Glycine—ALAS1—pituitary gland—breast cancer	0.000783	0.00684	CbGeAlD
Glycine—SLC6A9—lymph node—breast cancer	0.000782	0.00683	CbGeAlD
Glycine—ALAS1—adipose tissue—breast cancer	0.00078	0.00681	CbGeAlD
Glycine—GSS—nipple—breast cancer	0.000776	0.00678	CbGeAlD
Glycine—SHMT1—Vincristine—Vinorelbine—breast cancer	0.000775	0.209	CbGdCrCtD
Glycine—GCAT—bone marrow—breast cancer	0.000772	0.00674	CbGeAlD
Glycine—PIPOX—female gonad—breast cancer	0.000767	0.0067	CbGeAlD
Glycine—GLDC—endocrine gland—breast cancer	0.000764	0.00667	CbGeAlD
Glycine—GCAT—female gonad—breast cancer	0.000744	0.0065	CbGeAlD
Glycine—SHMT2—skin of body—breast cancer	0.000727	0.00635	CbGeAlD
Glycine—GARS—uterus—breast cancer	0.000726	0.00634	CbGeAlD
Glycine—ALAS1—female reproductive system—breast cancer	0.000717	0.00626	CbGeAlD
Glycine—PIPOX—endocrine gland—breast cancer	0.000713	0.00623	CbGeAlD
Glycine—GARS—pituitary gland—breast cancer	0.000713	0.00623	CbGeAlD
Glycine—GARS—adipose tissue—breast cancer	0.00071	0.0062	CbGeAlD
Glycine—ALAS1—adrenal gland—breast cancer	0.000699	0.00611	CbGeAlD
Glycine—GCAT—endocrine gland—breast cancer	0.000692	0.00604	CbGeAlD
Glycine—GATM—uterus—breast cancer	0.000689	0.00602	CbGeAlD
Glycine—SHMT2—endometrium—breast cancer	0.000685	0.00599	CbGeAlD
Glycine—GPR18—lymph node—breast cancer	0.00068	0.00594	CbGeAlD
Glycine—ALAS1—bone marrow—breast cancer	0.000677	0.00591	CbGeAlD
Glycine—GATM—adipose tissue—breast cancer	0.000674	0.00589	CbGeAlD
Glycine—GARS—female reproductive system—breast cancer	0.000653	0.0057	CbGeAlD
Glycine—ALAS1—female gonad—breast cancer	0.000652	0.0057	CbGeAlD
Glycine—GCSH—lymph node—breast cancer	0.000637	0.00557	CbGeAlD
Glycine—GARS—adrenal gland—breast cancer	0.000637	0.00556	CbGeAlD
Glycine—SHMT2—uterus—breast cancer	0.000632	0.00552	CbGeAlD
Glycine—SHMT1—endometrium—breast cancer	0.000624	0.00545	CbGeAlD
Glycine—SHMT1—Vinblastine—Vinorelbine—breast cancer	0.000623	0.168	CbGdCrCtD
Glycine—SHMT2—pituitary gland—breast cancer	0.00062	0.00542	CbGeAlD
Glycine—GATM—female reproductive system—breast cancer	0.00062	0.00541	CbGeAlD
Glycine—SHMT1—Vincristine—Vinblastine—breast cancer	0.000619	0.167	CbGdCrCtD
Glycine—SHMT2—adipose tissue—breast cancer	0.000618	0.0054	CbGeAlD
Glycine—GARS—bone marrow—breast cancer	0.000616	0.00538	CbGeAlD
Glycine—ALAS1—endocrine gland—breast cancer	0.000606	0.0053	CbGeAlD
Glycine—GATM—adrenal gland—breast cancer	0.000605	0.00528	CbGeAlD
Glycine—GARS—female gonad—breast cancer	0.000594	0.00519	CbGeAlD
Glycine—GLRB—pituitary gland—breast cancer	0.000581	0.00508	CbGeAlD
Glycine—GLRB—adipose tissue—breast cancer	0.000579	0.00506	CbGeAlD
Glycine—SLC16A10—nipple—breast cancer	0.000568	0.00497	CbGeAlD
Glycine—SHMT2—female reproductive system—breast cancer	0.000568	0.00496	CbGeAlD
Glycine—GATM—female gonad—breast cancer	0.000564	0.00493	CbGeAlD
Glycine—SHMT1—adipose tissue—breast cancer	0.000562	0.00491	CbGeAlD
Glycine—SHMT2—adrenal gland—breast cancer	0.000554	0.00484	CbGeAlD
Glycine—GARS—endocrine gland—breast cancer	0.000552	0.00482	CbGeAlD
Glycine—SHMT2—bone marrow—breast cancer	0.000536	0.00468	CbGeAlD
Glycine—GLDC—lymph node—breast cancer	0.000528	0.00461	CbGeAlD
Glycine—GATM—endocrine gland—breast cancer	0.000524	0.00458	CbGeAlD
Glycine—GLRB—adrenal gland—breast cancer	0.000519	0.00454	CbGeAlD
Glycine—SHMT1—female reproductive system—breast cancer	0.000517	0.00452	CbGeAlD
Glycine—SHMT2—female gonad—breast cancer	0.000517	0.00451	CbGeAlD
Glycine—SHMT1—adrenal gland—breast cancer	0.000504	0.00441	CbGeAlD
Glycine—GSS—skin of body—breast cancer	0.000497	0.00434	CbGeAlD
Glycine—SLC36A1—uterus—breast cancer	0.00049	0.00428	CbGeAlD
Glycine—SHMT1—bone marrow—breast cancer	0.000488	0.00426	CbGeAlD
Glycine—SHMT2—endocrine gland—breast cancer	0.000481	0.0042	CbGeAlD
Glycine—SLC36A1—adipose tissue—breast cancer	0.00048	0.00419	CbGeAlD
Glycine—GCAT—lymph node—breast cancer	0.000478	0.00418	CbGeAlD
Glycine—SHMT1—female gonad—breast cancer	0.00047	0.00411	CbGeAlD
Glycine—GSS—endometrium—breast cancer	0.000469	0.00409	CbGeAlD
Glycine—SLC36A1—female reproductive system—breast cancer	0.000441	0.00385	CbGeAlD
Glycine—SHMT1—endocrine gland—breast cancer	0.000437	0.00382	CbGeAlD
Glycine—GRIN2A—adrenal gland—breast cancer	0.000433	0.00378	CbGeAlD
Glycine—GSS—uterus—breast cancer	0.000432	0.00377	CbGeAlD
Glycine—SLC36A1—adrenal gland—breast cancer	0.00043	0.00376	CbGeAlD
Glycine—GSS—pituitary gland—breast cancer	0.000424	0.0037	CbGeAlD
Glycine—GSS—adipose tissue—breast cancer	0.000422	0.00369	CbGeAlD
Glycine—ALAS1—lymph node—breast cancer	0.000419	0.00366	CbGeAlD
Glycine—SLC36A1—bone marrow—breast cancer	0.000416	0.00364	CbGeAlD
Glycine—SLC36A1—female gonad—breast cancer	0.000401	0.0035	CbGeAlD
Glycine—GSS—female reproductive system—breast cancer	0.000388	0.00339	CbGeAlD
Glycine—SLC16A10—epithelium—breast cancer	0.000383	0.00334	CbGeAlD
Glycine—GARS—lymph node—breast cancer	0.000382	0.00334	CbGeAlD
Glycine—GSS—adrenal gland—breast cancer	0.000379	0.00331	CbGeAlD
Glycine—GRIN2A—endocrine gland—breast cancer	0.000375	0.00328	CbGeAlD
Glycine—SLC36A1—endocrine gland—breast cancer	0.000373	0.00326	CbGeAlD
Glycine—GSS—bone marrow—breast cancer	0.000366	0.0032	CbGeAlD
Glycine—GATM—lymph node—breast cancer	0.000362	0.00317	CbGeAlD
Glycine—GSS—female gonad—breast cancer	0.000353	0.00309	CbGeAlD
Glycine—SHMT2—lymph node—breast cancer	0.000332	0.0029	CbGeAlD
Glycine—GSS—endocrine gland—breast cancer	0.000328	0.00287	CbGeAlD
Glycine—GLRB—lymph node—breast cancer	0.000311	0.00272	CbGeAlD
Glycine—SLC16A10—adipose tissue—breast cancer	0.000309	0.0027	CbGeAlD
Glycine—SHMT1—lymph node—breast cancer	0.000302	0.00264	CbGeAlD
Glycine—SLC16A10—female reproductive system—breast cancer	0.000284	0.00248	CbGeAlD
Glycine—SLC36A1—lymph node—breast cancer	0.000258	0.00225	CbGeAlD
Glycine—Hypersensitivity—Idarubicin—breast cancer	0.000244	0.00216	CcSEcCtD
Glycine—Convulsion—Goserelin—breast cancer	0.000242	0.00214	CcSEcCtD
Glycine—Back pain—Vinorelbine—breast cancer	0.000242	0.00214	CcSEcCtD
Glycine—Thirst—Capecitabine—breast cancer	0.000241	0.00213	CcSEcCtD
Glycine—SLC16A10—endocrine gland—breast cancer	0.000241	0.0021	CbGeAlD
Glycine—Oedema—Tamoxifen—breast cancer	0.000239	0.00211	CcSEcCtD
Glycine—Diarrhoea—Anastrozole—breast cancer	0.000239	0.00211	CcSEcCtD
Glycine—Diarrhoea—Letrozole—breast cancer	0.000239	0.00211	CcSEcCtD
Glycine—Hyponatraemia—Docetaxel—breast cancer	0.000238	0.0021	CcSEcCtD
Glycine—Rhinitis—Irinotecan—breast cancer	0.000238	0.0021	CcSEcCtD
Glycine—Rhinitis—Mitoxantrone—breast cancer	0.000238	0.0021	CcSEcCtD
Glycine—Vomiting—Ixabepilone—breast cancer	0.000236	0.00208	CcSEcCtD
Glycine—Oedema—Melphalan—breast cancer	0.000234	0.00207	CcSEcCtD
Glycine—Nausea—Exemestane—breast cancer	0.000233	0.00206	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—breast cancer	0.000232	0.00205	CcSEcCtD
Glycine—Rhinitis—Gemcitabine—breast cancer	0.000231	0.00205	CcSEcCtD
Glycine—Back pain—Thiotepa—breast cancer	0.000231	0.00205	CcSEcCtD
Glycine—Dizziness—Letrozole—breast cancer	0.000231	0.00204	CcSEcCtD
Glycine—Dizziness—Anastrozole—breast cancer	0.000231	0.00204	CcSEcCtD
Glycine—Hyponatraemia—Capecitabine—breast cancer	0.00023	0.00204	CcSEcCtD
Glycine—Pain—Chlorambucil—breast cancer	0.000229	0.00203	CcSEcCtD
Glycine—Visual impairment—Irinotecan—breast cancer	0.000228	0.00202	CcSEcCtD
Glycine—Tachycardia—Melphalan—breast cancer	0.000228	0.00202	CcSEcCtD
Glycine—Oedema—Goserelin—breast cancer	0.000228	0.00202	CcSEcCtD
Glycine—Rhinitis—Fluorouracil—breast cancer	0.000228	0.00201	CcSEcCtD
Glycine—GSS—lymph node—breast cancer	0.000227	0.00198	CbGeAlD
Glycine—Diarrhoea—Raloxifene—breast cancer	0.000227	0.002	CcSEcCtD
Glycine—Diarrhoea—Idarubicin—breast cancer	0.000227	0.002	CcSEcCtD
Glycine—Vision blurred—Thiotepa—breast cancer	0.000225	0.00199	CcSEcCtD
Glycine—Vertigo—Vinorelbine—breast cancer	0.000225	0.00199	CcSEcCtD
Glycine—Tachycardia—Goserelin—breast cancer	0.000223	0.00197	CcSEcCtD
Glycine—Vomiting—Anastrozole—breast cancer	0.000222	0.00196	CcSEcCtD
Glycine—Vomiting—Letrozole—breast cancer	0.000222	0.00196	CcSEcCtD
Glycine—Dehydration—Docetaxel—breast cancer	0.00022	0.00195	CcSEcCtD
Glycine—Nausea—Ixabepilone—breast cancer	0.00022	0.00195	CcSEcCtD
Glycine—Dizziness—Raloxifene—breast cancer	0.000219	0.00194	CcSEcCtD
Glycine—Hypotension—Melphalan—breast cancer	0.000218	0.00193	CcSEcCtD
Glycine—Urinary retention—Capecitabine—breast cancer	0.000218	0.00193	CcSEcCtD
Glycine—Coma—Methotrexate—breast cancer	0.000215	0.0019	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—breast cancer	0.000214	0.00189	CcSEcCtD
Glycine—Dehydration—Capecitabine—breast cancer	0.000213	0.00189	CcSEcCtD
Glycine—Hypotension—Goserelin—breast cancer	0.000213	0.00189	CcSEcCtD
Glycine—Urticaria—Chlorambucil—breast cancer	0.000213	0.00188	CcSEcCtD
Glycine—Chills—Mitoxantrone—breast cancer	0.000213	0.00188	CcSEcCtD
Glycine—Chills—Irinotecan—breast cancer	0.000213	0.00188	CcSEcCtD
Glycine—Vomiting—Raloxifene—breast cancer	0.000211	0.00186	CcSEcCtD
Glycine—Vomiting—Idarubicin—breast cancer	0.000211	0.00186	CcSEcCtD
Glycine—Pain—Vinblastine—breast cancer	0.00021	0.00186	CcSEcCtD
Glycine—Nausea—Anastrozole—breast cancer	0.000207	0.00183	CcSEcCtD
Glycine—Nausea—Letrozole—breast cancer	0.000207	0.00183	CcSEcCtD
Glycine—Chills—Gemcitabine—breast cancer	0.000207	0.00183	CcSEcCtD
Glycine—Convulsion—Thiotepa—breast cancer	0.000207	0.00183	CcSEcCtD
Glycine—Pain—Tamoxifen—breast cancer	0.000204	0.00181	CcSEcCtD
Glycine—Coma—Epirubicin—breast cancer	0.000201	0.00178	CcSEcCtD
Glycine—Pain—Melphalan—breast cancer	0.0002	0.00177	CcSEcCtD
Glycine—Back pain—Mitoxantrone—breast cancer	0.0002	0.00177	CcSEcCtD
Glycine—Back pain—Irinotecan—breast cancer	0.0002	0.00177	CcSEcCtD
Glycine—Angina pectoris—Docetaxel—breast cancer	0.000199	0.00176	CcSEcCtD
Glycine—Tachycardia—Vinorelbine—breast cancer	0.000199	0.00176	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—breast cancer	0.000198	0.00175	CcSEcCtD
Glycine—Hypersensitivity—Chlorambucil—breast cancer	0.000198	0.00175	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—breast cancer	0.000197	0.00175	CcSEcCtD
Glycine—Nausea—Raloxifene—breast cancer	0.000197	0.00174	CcSEcCtD
Glycine—Nausea—Idarubicin—breast cancer	0.000197	0.00174	CcSEcCtD
Glycine—Pain—Goserelin—breast cancer	0.000195	0.00173	CcSEcCtD
Glycine—Vision blurred—Mitoxantrone—breast cancer	0.000194	0.00172	CcSEcCtD
Glycine—Back pain—Gemcitabine—breast cancer	0.000194	0.00172	CcSEcCtD
Glycine—Polyuria—Methotrexate—breast cancer	0.000194	0.00172	CcSEcCtD
Glycine—Rhinitis—Paclitaxel—breast cancer	0.000194	0.00171	CcSEcCtD
Glycine—Angina pectoris—Capecitabine—breast cancer	0.000193	0.00171	CcSEcCtD
Glycine—Hypotension—Vinorelbine—breast cancer	0.000191	0.00169	CcSEcCtD
Glycine—Tachycardia—Thiotepa—breast cancer	0.00019	0.00168	CcSEcCtD
Glycine—Urticaria—Tamoxifen—breast cancer	0.00019	0.00168	CcSEcCtD
Glycine—ALAS1—Dexamethasone—Fluoxymesterone—breast cancer	0.000187	0.0505	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Fluoxymesterone—breast cancer	0.000187	0.0505	CbGdCrCtD
Glycine—Visual impairment—Paclitaxel—breast cancer	0.000186	0.00165	CcSEcCtD
Glycine—Vision blurred—Fluorouracil—breast cancer	0.000186	0.00165	CcSEcCtD
Glycine—Coma—Doxorubicin—breast cancer	0.000186	0.00165	CcSEcCtD
Glycine—Urticaria—Melphalan—breast cancer	0.000186	0.00164	CcSEcCtD
Glycine—Vertigo—Irinotecan—breast cancer	0.000185	0.00164	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—breast cancer	0.000185	0.00163	CcSEcCtD
Glycine—Diarrhoea—Chlorambucil—breast cancer	0.000183	0.00162	CcSEcCtD
Glycine—Urticaria—Goserelin—breast cancer	0.000181	0.0016	CcSEcCtD
Glycine—Hypersensitivity—Vinblastine—breast cancer	0.000181	0.0016	CcSEcCtD
Glycine—Visual disturbance—Methotrexate—breast cancer	0.00018	0.00159	CcSEcCtD
Glycine—Convulsion—Mitoxantrone—breast cancer	0.000179	0.00158	CcSEcCtD
Glycine—Hypersensitivity—Tamoxifen—breast cancer	0.000176	0.00156	CcSEcCtD
Glycine—Pain—Vinorelbine—breast cancer	0.000175	0.00155	CcSEcCtD
Glycine—Chills—Paclitaxel—breast cancer	0.000173	0.00153	CcSEcCtD
Glycine—Hypersensitivity—Melphalan—breast cancer	0.000172	0.00152	CcSEcCtD
Glycine—Convulsion—Fluorouracil—breast cancer	0.000171	0.00152	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—breast cancer	0.000171	0.00151	CcSEcCtD
Glycine—Vomiting—Chlorambucil—breast cancer	0.00017	0.00151	CcSEcCtD
Glycine—Oedema—Irinotecan—breast cancer	0.000168	0.00149	CcSEcCtD
Glycine—Oedema—Mitoxantrone—breast cancer	0.000168	0.00149	CcSEcCtD
Glycine—Diarrhoea—Vinblastine—breast cancer	0.000168	0.00149	CcSEcCtD
Glycine—Hypersensitivity—Goserelin—breast cancer	0.000168	0.00149	CcSEcCtD
Glycine—Pain—Thiotepa—breast cancer	0.000167	0.00148	CcSEcCtD
Glycine—SLC16A10—lymph node—breast cancer	0.000166	0.00145	CbGeAlD
Glycine—Tachycardia—Mitoxantrone—breast cancer	0.000164	0.00145	CcSEcCtD
Glycine—Rhinitis—Docetaxel—breast cancer	0.000164	0.00145	CcSEcCtD
Glycine—Oedema—Gemcitabine—breast cancer	0.000164	0.00145	CcSEcCtD
Glycine—Diarrhoea—Tamoxifen—breast cancer	0.000163	0.00145	CcSEcCtD
Glycine—Back pain—Paclitaxel—breast cancer	0.000163	0.00144	CcSEcCtD
Glycine—Dizziness—Vinblastine—breast cancer	0.000162	0.00144	CcSEcCtD
Glycine—Urticaria—Vinorelbine—breast cancer	0.000162	0.00144	CcSEcCtD
Glycine—Oedema—Fluorouracil—breast cancer	0.000161	0.00143	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—breast cancer	0.00016	0.00142	CcSEcCtD
Glycine—Diarrhoea—Melphalan—breast cancer	0.00016	0.00142	CcSEcCtD
Glycine—Nausea—Chlorambucil—breast cancer	0.000159	0.00141	CcSEcCtD
Glycine—Rhinitis—Capecitabine—breast cancer	0.000159	0.00141	CcSEcCtD
Glycine—Vision blurred—Paclitaxel—breast cancer	0.000159	0.0014	CcSEcCtD
Glycine—Visual impairment—Docetaxel—breast cancer	0.000158	0.0014	CcSEcCtD
Glycine—Dizziness—Tamoxifen—breast cancer	0.000158	0.0014	CcSEcCtD
Glycine—Tachycardia—Fluorouracil—breast cancer	0.000157	0.00139	CcSEcCtD
Glycine—Hypotension—Mitoxantrone—breast cancer	0.000157	0.00139	CcSEcCtD
Glycine—Hypotension—Irinotecan—breast cancer	0.000157	0.00139	CcSEcCtD
Glycine—Vomiting—Vinblastine—breast cancer	0.000156	0.00138	CcSEcCtD
Glycine—Diarrhoea—Goserelin—breast cancer	0.000156	0.00138	CcSEcCtD
Glycine—Urticaria—Thiotepa—breast cancer	0.000155	0.00137	CcSEcCtD
Glycine—Hypotension—Gemcitabine—breast cancer	0.000153	0.00136	CcSEcCtD
Glycine—Visual impairment—Capecitabine—breast cancer	0.000153	0.00135	CcSEcCtD
Glycine—Vomiting—Tamoxifen—breast cancer	0.000152	0.00134	CcSEcCtD
Glycine—Vertigo—Paclitaxel—breast cancer	0.000151	0.00134	CcSEcCtD
Glycine—Dizziness—Goserelin—breast cancer	0.000151	0.00133	CcSEcCtD
Glycine—Hypotension—Fluorouracil—breast cancer	0.000151	0.00133	CcSEcCtD
Glycine—Hypersensitivity—Vinorelbine—breast cancer	0.00015	0.00133	CcSEcCtD
Glycine—Vomiting—Melphalan—breast cancer	0.000149	0.00131	CcSEcCtD
Glycine—Dehydration—Epirubicin—breast cancer	0.000149	0.00131	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—breast cancer	0.000148	0.00131	CcSEcCtD
Glycine—Chills—Docetaxel—breast cancer	0.000147	0.0013	CcSEcCtD
Glycine—Nausea—Vinblastine—breast cancer	0.000146	0.00129	CcSEcCtD
Glycine—Convulsion—Paclitaxel—breast cancer	0.000146	0.00129	CcSEcCtD
Glycine—Vomiting—Goserelin—breast cancer	0.000145	0.00128	CcSEcCtD
Glycine—Pain—Mitoxantrone—breast cancer	0.000144	0.00127	CcSEcCtD
Glycine—Pain—Irinotecan—breast cancer	0.000144	0.00127	CcSEcCtD
Glycine—Hypersensitivity—Thiotepa—breast cancer	0.000144	0.00127	CcSEcCtD
Glycine—Chills—Capecitabine—breast cancer	0.000142	0.00126	CcSEcCtD
Glycine—Nausea—Tamoxifen—breast cancer	0.000142	0.00125	CcSEcCtD
Glycine—Pain—Gemcitabine—breast cancer	0.00014	0.00124	CcSEcCtD
Glycine—Diarrhoea—Vinorelbine—breast cancer	0.00014	0.00124	CcSEcCtD
Glycine—Nausea—Melphalan—breast cancer	0.000139	0.00123	CcSEcCtD
Glycine—Back pain—Docetaxel—breast cancer	0.000138	0.00122	CcSEcCtD
Glycine—Pain—Fluorouracil—breast cancer	0.000138	0.00122	CcSEcCtD
Glycine—Dehydration—Doxorubicin—breast cancer	0.000137	0.00122	CcSEcCtD
Glycine—Oedema—Paclitaxel—breast cancer	0.000137	0.00122	CcSEcCtD
Glycine—Nausea—Goserelin—breast cancer	0.000135	0.0012	CcSEcCtD
Glycine—Dizziness—Vinorelbine—breast cancer	0.000135	0.00119	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—breast cancer	0.000135	0.00119	CcSEcCtD
Glycine—Tachycardia—Paclitaxel—breast cancer	0.000134	0.00119	CcSEcCtD
Glycine—Urticaria—Mitoxantrone—breast cancer	0.000134	0.00118	CcSEcCtD
Glycine—Back pain—Capecitabine—breast cancer	0.000134	0.00118	CcSEcCtD
Glycine—Diarrhoea—Thiotepa—breast cancer	0.000133	0.00118	CcSEcCtD
Glycine—Vision blurred—Capecitabine—breast cancer	0.00013	0.00115	CcSEcCtD
Glycine—Vomiting—Vinorelbine—breast cancer	0.00013	0.00115	CcSEcCtD
Glycine—Dizziness—Thiotepa—breast cancer	0.000129	0.00114	CcSEcCtD
Glycine—Hypotension—Paclitaxel—breast cancer	0.000128	0.00114	CcSEcCtD
Glycine—Urticaria—Fluorouracil—breast cancer	0.000128	0.00113	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—breast cancer	0.000124	0.0011	CcSEcCtD
Glycine—Vertigo—Capecitabine—breast cancer	0.000124	0.0011	CcSEcCtD
Glycine—Hypersensitivity—Irinotecan—breast cancer	0.000124	0.0011	CcSEcCtD
Glycine—Hypersensitivity—Mitoxantrone—breast cancer	0.000124	0.0011	CcSEcCtD
Glycine—Vomiting—Thiotepa—breast cancer	0.000124	0.0011	CcSEcCtD
Glycine—Convulsion—Docetaxel—breast cancer	0.000124	0.00109	CcSEcCtD
Glycine—Nausea—Vinorelbine—breast cancer	0.000121	0.00107	CcSEcCtD
Glycine—Hypersensitivity—Fluorouracil—breast cancer	0.000119	0.00105	CcSEcCtD
Glycine—Pain—Paclitaxel—breast cancer	0.000117	0.00104	CcSEcCtD
Glycine—Oedema—Docetaxel—breast cancer	0.000116	0.00103	CcSEcCtD
Glycine—Nausea—Thiotepa—breast cancer	0.000116	0.00102	CcSEcCtD
Glycine—Diarrhoea—Mitoxantrone—breast cancer	0.000115	0.00102	CcSEcCtD
Glycine—Diarrhoea—Irinotecan—breast cancer	0.000115	0.00102	CcSEcCtD
Glycine—Visual impairment—Methotrexate—breast cancer	0.000114	0.00101	CcSEcCtD
Glycine—Tachycardia—Docetaxel—breast cancer	0.000114	0.00101	CcSEcCtD
Glycine—Oedema—Capecitabine—breast cancer	0.000113	0.000997	CcSEcCtD
Glycine—Diarrhoea—Gemcitabine—breast cancer	0.000112	0.000993	CcSEcCtD
Glycine—Dizziness—Irinotecan—breast cancer	0.000111	0.000985	CcSEcCtD
Glycine—Rhinitis—Epirubicin—breast cancer	0.000111	0.00098	CcSEcCtD
Glycine—Diarrhoea—Fluorouracil—breast cancer	0.00011	0.000977	CcSEcCtD
Glycine—Tachycardia—Capecitabine—breast cancer	0.00011	0.000973	CcSEcCtD
Glycine—Urticaria—Paclitaxel—breast cancer	0.000109	0.000965	CcSEcCtD
Glycine—Hypotension—Docetaxel—breast cancer	0.000109	0.000963	CcSEcCtD
Glycine—Vomiting—Irinotecan—breast cancer	0.000107	0.000947	CcSEcCtD
Glycine—Vomiting—Mitoxantrone—breast cancer	0.000107	0.000947	CcSEcCtD
Glycine—Dizziness—Fluorouracil—breast cancer	0.000107	0.000944	CcSEcCtD
Glycine—Visual impairment—Epirubicin—breast cancer	0.000107	0.000942	CcSEcCtD
Glycine—Chills—Methotrexate—breast cancer	0.000106	0.000938	CcSEcCtD
Glycine—Hypotension—Capecitabine—breast cancer	0.000105	0.000932	CcSEcCtD
Glycine—Vomiting—Gemcitabine—breast cancer	0.000104	0.000923	CcSEcCtD
Glycine—Vomiting—Fluorouracil—breast cancer	0.000103	0.000907	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—breast cancer	0.000103	0.000907	CcSEcCtD
Glycine—Hypersensitivity—Paclitaxel—breast cancer	0.000101	0.000895	CcSEcCtD
Glycine—Nausea—Irinotecan—breast cancer	0.0001	0.000885	CcSEcCtD
Glycine—Nausea—Mitoxantrone—breast cancer	0.0001	0.000885	CcSEcCtD
Glycine—Pain—Docetaxel—breast cancer	9.96e-05	0.000881	CcSEcCtD
Glycine—Back pain—Methotrexate—breast cancer	9.95e-05	0.00088	CcSEcCtD
Glycine—Chills—Epirubicin—breast cancer	9.92e-05	0.000878	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—breast cancer	9.86e-05	0.000872	CcSEcCtD
Glycine—Nausea—Gemcitabine—breast cancer	9.74e-05	0.000862	CcSEcCtD
Glycine—Vision blurred—Methotrexate—breast cancer	9.69e-05	0.000857	CcSEcCtD
Glycine—Pain—Capecitabine—breast cancer	9.64e-05	0.000853	CcSEcCtD
Glycine—Nausea—Fluorouracil—breast cancer	9.58e-05	0.000848	CcSEcCtD
Glycine—Diarrhoea—Paclitaxel—breast cancer	9.4e-05	0.000832	CcSEcCtD
Glycine—Back pain—Epirubicin—breast cancer	9.31e-05	0.000823	CcSEcCtD
Glycine—Vertigo—Methotrexate—breast cancer	9.24e-05	0.000817	CcSEcCtD
Glycine—Chills—Doxorubicin—breast cancer	9.18e-05	0.000812	CcSEcCtD
Glycine—Dizziness—Paclitaxel—breast cancer	9.08e-05	0.000804	CcSEcCtD
Glycine—Vision blurred—Epirubicin—breast cancer	9.07e-05	0.000802	CcSEcCtD
Glycine—Urticaria—Capecitabine—breast cancer	8.95e-05	0.000792	CcSEcCtD
Glycine—Convulsion—Methotrexate—breast cancer	8.91e-05	0.000788	CcSEcCtD
Glycine—Vomiting—Paclitaxel—breast cancer	8.73e-05	0.000773	CcSEcCtD
Glycine—Vertigo—Epirubicin—breast cancer	8.64e-05	0.000765	CcSEcCtD
Glycine—Back pain—Doxorubicin—breast cancer	8.61e-05	0.000762	CcSEcCtD
Glycine—Hypersensitivity—Docetaxel—breast cancer	8.58e-05	0.000759	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—breast cancer	8.39e-05	0.000742	CcSEcCtD
Glycine—Convulsion—Epirubicin—breast cancer	8.34e-05	0.000738	CcSEcCtD
Glycine—Hypersensitivity—Capecitabine—breast cancer	8.3e-05	0.000735	CcSEcCtD
Glycine—Nausea—Paclitaxel—breast cancer	8.16e-05	0.000722	CcSEcCtD
Glycine—Vertigo—Doxorubicin—breast cancer	8e-05	0.000708	CcSEcCtD
Glycine—Diarrhoea—Docetaxel—breast cancer	7.97e-05	0.000705	CcSEcCtD
Glycine—Oedema—Epirubicin—breast cancer	7.85e-05	0.000695	CcSEcCtD
Glycine—Hypotension—Methotrexate—breast cancer	7.84e-05	0.000694	CcSEcCtD
Glycine—Convulsion—Doxorubicin—breast cancer	7.71e-05	0.000683	CcSEcCtD
Glycine—Diarrhoea—Capecitabine—breast cancer	7.71e-05	0.000682	CcSEcCtD
Glycine—Dizziness—Docetaxel—breast cancer	7.7e-05	0.000681	CcSEcCtD
Glycine—Tachycardia—Epirubicin—breast cancer	7.66e-05	0.000678	CcSEcCtD
Glycine—Dizziness—Capecitabine—breast cancer	7.45e-05	0.00066	CcSEcCtD
Glycine—Vomiting—Docetaxel—breast cancer	7.4e-05	0.000655	CcSEcCtD
Glycine—Hypotension—Epirubicin—breast cancer	7.34e-05	0.000649	CcSEcCtD
Glycine—Oedema—Doxorubicin—breast cancer	7.27e-05	0.000643	CcSEcCtD
Glycine—Pain—Methotrexate—breast cancer	7.18e-05	0.000635	CcSEcCtD
Glycine—Vomiting—Capecitabine—breast cancer	7.17e-05	0.000634	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—breast cancer	7.09e-05	0.000627	CcSEcCtD
Glycine—Nausea—Docetaxel—breast cancer	6.92e-05	0.000612	CcSEcCtD
Glycine—Hypotension—Doxorubicin—breast cancer	6.79e-05	0.000601	CcSEcCtD
Glycine—Pain—Epirubicin—breast cancer	6.72e-05	0.000594	CcSEcCtD
Glycine—Nausea—Capecitabine—breast cancer	6.7e-05	0.000592	CcSEcCtD
Glycine—Urticaria—Methotrexate—breast cancer	6.67e-05	0.00059	CcSEcCtD
Glycine—Urticaria—Epirubicin—breast cancer	6.24e-05	0.000552	CcSEcCtD
Glycine—Pain—Doxorubicin—breast cancer	6.21e-05	0.00055	CcSEcCtD
Glycine—Hypersensitivity—Methotrexate—breast cancer	6.18e-05	0.000547	CcSEcCtD
Glycine—Hypersensitivity—Epirubicin—breast cancer	5.79e-05	0.000512	CcSEcCtD
Glycine—Urticaria—Doxorubicin—breast cancer	5.77e-05	0.000511	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—breast cancer	5.74e-05	0.000508	CcSEcCtD
Glycine—Dizziness—Methotrexate—breast cancer	5.55e-05	0.000491	CcSEcCtD
Glycine—Diarrhoea—Epirubicin—breast cancer	5.37e-05	0.000475	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—breast cancer	5.35e-05	0.000474	CcSEcCtD
Glycine—Vomiting—Methotrexate—breast cancer	5.34e-05	0.000472	CcSEcCtD
Glycine—Dizziness—Epirubicin—breast cancer	5.19e-05	0.000459	CcSEcCtD
Glycine—Vomiting—Epirubicin—breast cancer	4.99e-05	0.000442	CcSEcCtD
Glycine—Nausea—Methotrexate—breast cancer	4.98e-05	0.000441	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—breast cancer	4.97e-05	0.00044	CcSEcCtD
Glycine—Dizziness—Doxorubicin—breast cancer	4.8e-05	0.000425	CcSEcCtD
Glycine—Nausea—Epirubicin—breast cancer	4.66e-05	0.000413	CcSEcCtD
Glycine—Vomiting—Doxorubicin—breast cancer	4.62e-05	0.000409	CcSEcCtD
Glycine—Nausea—Doxorubicin—breast cancer	4.32e-05	0.000382	CcSEcCtD
Glycine—SHMT1—Disease—SMAD4—breast cancer	9.93e-06	5.47e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PLA2G4A—breast cancer	9.9e-06	5.46e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NCOR1—breast cancer	9.9e-06	5.46e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HSP90AA1—breast cancer	9.9e-06	5.46e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—breast cancer	9.9e-06	5.46e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1B1—breast cancer	9.84e-06	5.42e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR1—breast cancer	9.8e-06	5.4e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MAPK3—breast cancer	9.76e-06	5.38e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—breast cancer	9.7e-06	5.35e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HES1—breast cancer	9.69e-06	5.34e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—breast cancer	9.65e-06	5.32e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HSP90AA1—breast cancer	9.65e-06	5.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NCOR1—breast cancer	9.64e-06	5.31e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NCOA1—breast cancer	9.63e-06	5.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF1—breast cancer	9.53e-06	5.25e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—breast cancer	9.5e-06	5.23e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—STK11—breast cancer	9.49e-06	5.23e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP19A1—breast cancer	9.49e-06	5.23e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CAV1—breast cancer	9.49e-06	5.23e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPX1—breast cancer	9.48e-06	5.23e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NRG1—breast cancer	9.46e-06	5.22e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LEP—breast cancer	9.42e-06	5.19e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—H2AFX—breast cancer	9.39e-06	5.18e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP1A1—breast cancer	9.39e-06	5.17e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NCOA1—breast cancer	9.39e-06	5.17e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—RAF1—breast cancer	9.34e-06	5.15e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CAV1—breast cancer	9.34e-06	5.15e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ERCC2—breast cancer	9.31e-06	5.13e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—STK11—breast cancer	9.25e-06	5.1e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP19A1—breast cancer	9.25e-06	5.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—breast cancer	9.23e-06	5.09e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CAV1—breast cancer	9.19e-06	5.07e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERCC2—breast cancer	9.06e-06	5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—breast cancer	9e-06	4.96e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—breast cancer	8.94e-06	4.93e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—breast cancer	8.94e-06	4.93e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—breast cancer	8.94e-06	4.93e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—breast cancer	8.94e-06	4.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FN1—breast cancer	8.89e-06	4.9e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—breast cancer	8.89e-06	4.9e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB3—breast cancer	8.86e-06	4.89e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR2—breast cancer	8.85e-06	4.88e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—breast cancer	8.83e-06	4.87e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—breast cancer	8.83e-06	4.87e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—COMT—breast cancer	8.83e-06	4.87e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—breast cancer	8.83e-06	4.87e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—breast cancer	8.83e-06	4.87e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—breast cancer	8.78e-06	4.84e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.78e-06	4.84e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NFKBIA—breast cancer	8.78e-06	4.84e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—breast cancer	8.75e-06	4.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOTCH1—breast cancer	8.7e-06	4.79e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HMOX1—breast cancer	8.66e-06	4.78e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—breast cancer	8.65e-06	4.77e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ITPR1—breast cancer	8.64e-06	4.76e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—COMT—breast cancer	8.6e-06	4.74e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—breast cancer	8.56e-06	4.72e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—breast cancer	8.53e-06	4.7e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—breast cancer	8.52e-06	4.7e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—breast cancer	8.5e-06	4.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—breast cancer	8.5e-06	4.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—breast cancer	8.5e-06	4.69e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—breast cancer	8.49e-06	4.68e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMOX1—breast cancer	8.44e-06	4.65e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NOS3—breast cancer	8.44e-06	4.65e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NOS3—breast cancer	8.44e-06	4.65e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NOS3—breast cancer	8.44e-06	4.65e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—NOS3—breast cancer	8.44e-06	4.65e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ITPR1—breast cancer	8.42e-06	4.64e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—breast cancer	8.42e-06	4.64e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGF—breast cancer	8.41e-06	4.63e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—breast cancer	8.38e-06	4.62e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—breast cancer	8.32e-06	4.58e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR1—breast cancer	8.25e-06	4.55e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMS—breast cancer	8.17e-06	4.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK3—breast cancer	8.14e-06	4.49e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—breast cancer	8.12e-06	4.48e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—breast cancer	8.1e-06	4.47e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—breast cancer	8.07e-06	4.45e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAV1—breast cancer	8.07e-06	4.45e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NCOR1—breast cancer	8.07e-06	4.45e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PLA2G4A—breast cancer	8.07e-06	4.45e-05	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—breast cancer	8.07e-06	4.45e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—NOS3—breast cancer	8.05e-06	4.44e-05	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—breast cancer	8.04e-06	4.43e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BRAF—breast cancer	7.99e-06	4.41e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMS—breast cancer	7.96e-06	4.39e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NCOR1—breast cancer	7.87e-06	4.34e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PLA2G4A—breast cancer	7.87e-06	4.34e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—breast cancer	7.87e-06	4.34e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CAV1—breast cancer	7.86e-06	4.33e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—breast cancer	7.79e-06	4.3e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—breast cancer	7.79e-06	4.3e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—breast cancer	7.79e-06	4.3e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—breast cancer	7.79e-06	4.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—breast cancer	7.79e-06	4.29e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT2—breast cancer	7.78e-06	4.29e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—breast cancer	7.75e-06	4.27e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPX1—breast cancer	7.73e-06	4.26e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—breast cancer	7.72e-06	4.26e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—breast cancer	7.72e-06	4.26e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—breast cancer	7.72e-06	4.26e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—breast cancer	7.72e-06	4.26e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1A1—breast cancer	7.65e-06	4.22e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—breast cancer	7.6e-06	4.19e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ERCC2—breast cancer	7.59e-06	4.18e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GPX1—breast cancer	7.53e-06	4.15e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—breast cancer	7.5e-06	4.14e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—breast cancer	7.48e-06	4.12e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1A1—breast cancer	7.46e-06	4.11e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—breast cancer	7.43e-06	4.1e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—breast cancer	7.4e-06	4.08e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ERCC2—breast cancer	7.4e-06	4.08e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SERPINE1—breast cancer	7.39e-06	4.08e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS2—breast cancer	7.39e-06	4.07e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—breast cancer	7.37e-06	4.06e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—breast cancer	7.36e-06	4.06e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—breast cancer	7.35e-06	4.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—breast cancer	7.32e-06	4.03e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOTCH1—breast cancer	7.32e-06	4.03e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—breast cancer	7.27e-06	4.01e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—NOS3—breast cancer	7.18e-06	3.96e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—breast cancer	7.16e-06	3.95e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—breast cancer	7.16e-06	3.95e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—breast cancer	7.13e-06	3.93e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGF—breast cancer	7.07e-06	3.9e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOS3—breast cancer	7.06e-06	3.89e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—breast cancer	6.95e-06	3.83e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NOS3—breast cancer	6.95e-06	3.83e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—breast cancer	6.73e-06	3.71e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—breast cancer	6.73e-06	3.71e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—breast cancer	6.73e-06	3.71e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—breast cancer	6.73e-06	3.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BRAF—breast cancer	6.73e-06	3.71e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—breast cancer	6.72e-06	3.71e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MDM2—breast cancer	6.7e-06	3.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RAF1—breast cancer	6.67e-06	3.68e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RELA—breast cancer	6.64e-06	3.66e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—breast cancer	6.63e-06	3.65e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—breast cancer	6.6e-06	3.64e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—breast cancer	6.59e-06	3.63e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAV1—breast cancer	6.58e-06	3.63e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—breast cancer	6.57e-06	3.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT2—breast cancer	6.55e-06	3.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—breast cancer	6.52e-06	3.59e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—breast cancer	6.52e-06	3.59e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—breast cancer	6.46e-06	3.56e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—breast cancer	6.42e-06	3.54e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—breast cancer	6.42e-06	3.54e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAV1—breast cancer	6.41e-06	3.53e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—breast cancer	6.38e-06	3.52e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—breast cancer	6.36e-06	3.51e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—breast cancer	6.29e-06	3.47e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—breast cancer	6.28e-06	3.46e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—breast cancer	6.27e-06	3.46e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—breast cancer	6.26e-06	3.45e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SERPINE1—breast cancer	6.22e-06	3.43e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—breast cancer	6.22e-06	3.43e-05	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—breast cancer	6.16e-06	3.4e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—breast cancer	6.12e-06	3.37e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NOS3—breast cancer	6.1e-06	3.36e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—breast cancer	6.05e-06	3.33e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—breast cancer	5.99e-06	3.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—breast cancer	5.99e-06	3.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—breast cancer	5.98e-06	3.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—breast cancer	5.95e-06	3.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS3—breast cancer	5.94e-06	3.28e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—breast cancer	5.84e-06	3.22e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—breast cancer	5.83e-06	3.22e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUN—breast cancer	5.82e-06	3.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—breast cancer	5.78e-06	3.18e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—breast cancer	5.73e-06	3.16e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—RAF1—breast cancer	5.68e-06	3.13e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—breast cancer	5.66e-06	3.12e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—breast cancer	5.64e-06	3.11e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MDM2—breast cancer	5.64e-06	3.11e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—breast cancer	5.63e-06	3.11e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—breast cancer	5.63e-06	3.1e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—RAF1—breast cancer	5.62e-06	3.1e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—breast cancer	5.58e-06	3.08e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—breast cancer	5.56e-06	3.06e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—breast cancer	5.55e-06	3.06e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK8—breast cancer	5.51e-06	3.04e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—breast cancer	5.49e-06	3.03e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—breast cancer	5.48e-06	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—breast cancer	5.48e-06	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—breast cancer	5.47e-06	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—breast cancer	5.43e-06	3e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—breast cancer	5.27e-06	2.9e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—breast cancer	5.22e-06	2.88e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—breast cancer	5.2e-06	2.87e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—breast cancer	5.15e-06	2.84e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—breast cancer	5.14e-06	2.83e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—breast cancer	5.12e-06	2.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—breast cancer	5.09e-06	2.8e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—breast cancer	5.07e-06	2.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—breast cancer	5.04e-06	2.78e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NOS3—breast cancer	4.98e-06	2.74e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—breast cancer	4.87e-06	2.68e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—breast cancer	4.86e-06	2.68e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NOS3—breast cancer	4.85e-06	2.67e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK3—breast cancer	4.81e-06	2.65e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—breast cancer	4.75e-06	2.62e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—breast cancer	4.75e-06	2.62e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—breast cancer	4.75e-06	2.62e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—breast cancer	4.75e-06	2.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—breast cancer	4.75e-06	2.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—breast cancer	4.74e-06	2.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—breast cancer	4.68e-06	2.58e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—breast cancer	4.67e-06	2.57e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—breast cancer	4.59e-06	2.53e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—breast cancer	4.58e-06	2.52e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—breast cancer	4.55e-06	2.51e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—breast cancer	4.53e-06	2.5e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—breast cancer	4.48e-06	2.47e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—breast cancer	4.43e-06	2.44e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—breast cancer	4.39e-06	2.42e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—breast cancer	4.32e-06	2.38e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—breast cancer	4.24e-06	2.34e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK3—breast cancer	4.05e-06	2.23e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—breast cancer	4.04e-06	2.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—breast cancer	3.97e-06	2.19e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—breast cancer	3.97e-06	2.19e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—breast cancer	3.94e-06	2.17e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—breast cancer	3.93e-06	2.17e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—breast cancer	3.91e-06	2.16e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—breast cancer	3.88e-06	2.14e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—breast cancer	3.88e-06	2.14e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—breast cancer	3.88e-06	2.14e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—breast cancer	3.88e-06	2.14e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—breast cancer	3.87e-06	2.13e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—breast cancer	3.85e-06	2.12e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—breast cancer	3.84e-06	2.12e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—breast cancer	3.7e-06	2.04e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—breast cancer	3.68e-06	2.03e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—breast cancer	3.64e-06	2.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—breast cancer	3.52e-06	1.94e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—breast cancer	3.43e-06	1.89e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—breast cancer	3.34e-06	1.84e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—breast cancer	3.3e-06	1.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—breast cancer	3.25e-06	1.79e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—breast cancer	3.2e-06	1.76e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—breast cancer	3.09e-06	1.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—breast cancer	2.96e-06	1.63e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—breast cancer	2.81e-06	1.55e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—breast cancer	2.8e-06	1.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—breast cancer	2.73e-06	1.51e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—breast cancer	2.73e-06	1.5e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—breast cancer	2.29e-06	1.26e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—breast cancer	2.23e-06	1.23e-05	CbGpPWpGaD
